Accession Number: | 0001179110-19-001906 |
Date: | 2019-02-12 |
Issuer: | MOMENTA PHARMACEUTICALS INC (MNTA) |
Original Submission Date: |
FIER IAN
C/O MOMENTA PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-02-12 | M | 17,500 | a | $0.00 | 97,820 | direct | ||
COMMON STOCK | 2019-02-13 | S | 5,453 | d | $12.70 | 92,367 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2019-02-12 | deemed execution date | M | 17,500 (d) | common stock 17,500 | $0.00 | 17,500 | direct |
ID | footnote |
---|---|
f1 | shares received pursuant to settlement of restricted stock units that were granted on february 12, 2018. |
f2 | this transaction was effected pursuant to a rule 10b5-1 trading plan. |
f3 | restricted stock units convert into common stock on a one-for-one basis. |
f4 | subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date. |